112 related articles for article (PubMed ID: 12440959)
41. Molecular cloning of membrane cofactor protein (MCP; CD46) on B95a cell, an Epstein-Barr virus-transformed marmoset B cell line: B95a-MCP is susceptible to infection by the CAM, but not the Nagahata strain of the measles virus.
Murakami Y; Seya T; Kurita M; Fukui A; Ueda S; Nagasawa S
Biochem J; 1998 Mar; 330 ( Pt 3)(Pt 3):1351-9. PubMed ID: 9494106
[TBL] [Abstract][Full Text] [Related]
42. Post-translational modification and intracellular localization of a splice product of CD46 cloned from human testis: role of the intracellular domains in O-glycosylation.
Hara T; Suzuki Y; Nakazawa T; Nishimura H; Nagasawa S; Nishiguchi M; Matsumoto M; Hatanaka M; Kitamura M; Seya T
Immunology; 1998 Apr; 93(4):546-55. PubMed ID: 9659228
[TBL] [Abstract][Full Text] [Related]
43. Functional modulation of human macrophages through CD46 (measles virus receptor): production of IL-12 p40 and nitric oxide in association with recruitment of protein-tyrosine phosphatase SHP-1 to CD46.
Kurita-Taniguchi M; Fukui A; Hazeki K; Hirano A; Tsuji S; Matsumoto M; Watanabe M; Ueda S; Seya T
J Immunol; 2000 Nov; 165(9):5143-52. PubMed ID: 11046046
[TBL] [Abstract][Full Text] [Related]
44. Characterization of the active sites in decay-accelerating factor.
Kuttner-Kondo LA; Mitchell L; Hourcade DE; Medof ME
J Immunol; 2001 Aug; 167(4):2164-71. PubMed ID: 11490001
[TBL] [Abstract][Full Text] [Related]
45. Modulation of complement regulatory function and measles virus receptor function by the serine-threonine-rich domains of membrane cofactor protein (CD46).
Iwata K; Seya T; Ueda S; Ariga H; Nagasawa S
Biochem J; 1994 Nov; 304 ( Pt 1)(Pt 1):169-75. PubMed ID: 7998929
[TBL] [Abstract][Full Text] [Related]
46. Domain swapping reveals complement control protein modules critical for imparting cofactor and decay-accelerating activities in vaccinia virus complement control protein.
Ahmad M; Raut S; Pyaram K; Kamble A; Mullick J; Sahu A
J Immunol; 2010 Nov; 185(10):6128-37. PubMed ID: 20956343
[TBL] [Abstract][Full Text] [Related]
47. [Functions and structure of complement inactivators in membrane proteins. 3). Membrane cofactor protein].
Seya T
Nihon Rinsho; 1988 Sep; 46(9):1933-7. PubMed ID: 3266511
[No Abstract] [Full Text] [Related]
48. Ligation of human CD46 with purified complement C3b or F(ab')(2) of monoclonal antibodies enhances isoform-specific interferon gamma-dependent nitric oxide production in macrophages.
Hirano A; Kurita-Taniguchi M; Katayama Y; Matsumoto M; Wong TC; Seya T
J Biochem; 2002 Jul; 132(1):83-91. PubMed ID: 12097164
[TBL] [Abstract][Full Text] [Related]
49. Expression of a hybrid complement regulatory protein, membrane cofactor protein decay accelerating factor on Chinese hamster ovary. Comparison of its regulatory effect with those of decay accelerating factor and membrane cofactor protein.
Iwata K; Seya T; Ariga H; Nagasawa S
J Immunol; 1994 Apr; 152(7):3436-44. PubMed ID: 7511647
[TBL] [Abstract][Full Text] [Related]
50. Membrane cofactor protein (MCP; CD46): isoform-specific tyrosine phosphorylation.
Wang G; Liszewski MK; Chan AC; Atkinson JP
J Immunol; 2000 Feb; 164(4):1839-46. PubMed ID: 10657632
[TBL] [Abstract][Full Text] [Related]
51. Factor I-dependent inactivation of human complement C4b of the classical pathway by C3b/C4b receptor (CR1, CD35) and membrane cofactor protein (MCP, CD46).
Masaki T; Matsumoto M; Nakanishi I; Yasuda R; Seya T
J Biochem; 1992 May; 111(5):573-8. PubMed ID: 1386357
[TBL] [Abstract][Full Text] [Related]
52. Membrane cofactor protein (MCP or CD46): newest member of the regulators of complement activation gene cluster.
Liszewski MK; Post TW; Atkinson JP
Annu Rev Immunol; 1991; 9():431-55. PubMed ID: 1910685
[TBL] [Abstract][Full Text] [Related]
53. The expression of the complement regulators CD46, CD55, and CD59 by human sperm does not protect them from antisperm antibody- and complement-mediated immune injury.
D'Cruz OJ; Haas GG
Fertil Steril; 1993 Apr; 59(4):876-84. PubMed ID: 7681414
[TBL] [Abstract][Full Text] [Related]
54. Expression of complement regulating proteins on FDC.
Schgmitz J; Petrasch S; Mews I; van Lunzen J; Kluxen B; Würzner R; Schmitz H; Racz P
Adv Exp Med Biol; 1995; 378():293-5. PubMed ID: 8526076
[No Abstract] [Full Text] [Related]
55. A structural template for gp130-cytokine signaling assemblies.
Chow DC; Brevnova L; He XL; Martick MM; Bankovich A; Garcia KC
Biochim Biophys Acta; 2002 Nov; 1592(3):225-35. PubMed ID: 12421668
[TBL] [Abstract][Full Text] [Related]
56. Viral regulators of complement activation: structure, function and evolution.
Ojha H; Panwar HS; Gorham RD; Morikis D; Sahu A
Mol Immunol; 2014 Oct; 61(2):89-99. PubMed ID: 24976595
[TBL] [Abstract][Full Text] [Related]
57. A therapeutic human anti-idiotypic antibody mimics CD55 in three distinct regions.
Spendlove L; Li L; Potter V; Christiansen D; Loveland BE; Durrant LG
Eur J Immunol; 2000 Oct; 30(10):2944-53. PubMed ID: 11069077
[TBL] [Abstract][Full Text] [Related]
58. A 3D model for the measles virus receptor CD46 based on homology modeling, Monte Carlo simulations, and hemagglutinin binding studies.
Mumenthaler C; Schneider U; Buchholz CJ; Koller D; Braun W; Cattaneo R
Protein Sci; 1997 Mar; 6(3):588-97. PubMed ID: 9070441
[TBL] [Abstract][Full Text] [Related]
59. Efficiency of measles virus entry and dissemination through different receptors.
Schneider U; von Messling V; Devaux P; Cattaneo R
J Virol; 2002 Aug; 76(15):7460-7. PubMed ID: 12097558
[TBL] [Abstract][Full Text] [Related]
60. Coordinate functions of multiple complement regulating molecules, CD46, CD55, and CD59.
Loveland BE; Szokolai K; Johnstone RW; McKenzie IF
Transplant Proc; 1994 Jun; 26(3):1070-1. PubMed ID: 7518104
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
